Yvonne Y. Chen, Ph.D.
Affiliations: | Chemical Engineering | University of California, Los Angeles, Los Angeles, CA |
Google:
"Yvonne Chen"Mean distance: 10.36 | S | N | B | C | P |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cabera A, Edelstein HI, Glykofrydis F, et al. (2022) The sound of silence: Transgene silencing in mammalian cell engineering. Cell Systems. 13: 950-973 |
| Li JH, Chen YY. (2020) A Fresh Approach to Targeting Aging Cells: CAR-T Cells Enhance Senolytic Specificity. Cell Stem Cell. 27: 192-194 |
| Jayaraman J, Mellody MP, Hou AJ, et al. (2020) CAR-T design: Elements and their synergistic function. Ebiomedicine. 58: 102931 |
| Hong M, Clubb JD, Chen YY. (2020) Engineering CAR-T Cells for Next-Generation Cancer Therapy. Cancer Cell |
| Zah E, Nam E, Bhuvan V, et al. (2020) Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma. Nature Communications. 11: 2283 |
| Chang ZL, Hou AJ, Chen YY. (2020) Engineering primary T cells with chimeric antigen receptors for rewired responses to soluble ligands. Nature Protocols |
| Chen YY, Van Deventer JA. (2019) Editorial overview: Pharmaceutical biotechnology: new frontiers in protein, gene, and cell therapies. Current Opinion in Biotechnology |
| Chen LC, Chen YY. (2019) Outsmarting and outmuscling cancer cells with synthetic and systems immunology. Current Opinion in Biotechnology. 60: 111-118 |
| Chen YY. (2018) Increasing T Cell Versatility with SUPRA CARs. Cell. 173: 1316-1317 |
| Chang ZL, Lorenzini MH, Chen X, et al. (2018) Rewiring T-cell responses to soluble factors with chimeric antigen receptors. Nature Chemical Biology |